| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-362 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-743
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6876 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N- |
| filingDate |
2004-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17c2c81dadfa3f3efb4eeaa742967ad3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b944b4227436ef5bd8cf79e6332b233e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67e72ab8bc6ffabfa547cd9baf50c6c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcf6e32900c1bea02d775b42d11b0618
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74e666df1f4850135d0799374b1e0fbe |
| publicationDate |
2007-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-PI0414857-A |
| titleOfInvention |
dmbt1 as a clinical marker and its use |
| abstract |
"DMBT1 AS A CLINICAL MARKER AND ITS USE". The present invention provides methods for determining the estrogenic activity of a compound, while including contacting an estrogen responsive system having a gene under the control of a DMBT1 regulatory sequence with a test compound and determining how the test compound affects expression of the estrogen. gene. The invention further provides the determination of progestogenic activity of a compound, which includes contacting an estrogen and progesterone responsive system having a gene under the control of a DMBT1 regulatory sequence with an estrogenic activity and a test compound and determining how the compound of test effects gene expression. Nucleic acids and cell-based systems that include a portion of the DMBT1 regulatory sequence useful for these methods are also provided. |
| priorityDate |
2003-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |